Astella Investimentos

Astella Investimentos is one of Brazil’s most established early-stage software-focused funds, with a long track record across SaaS, fintech, and increasingly healthtech. The firm has built its reputation on a proprietary methodology for guiding software startups through the messy seed-to-Series-A scaling phase, which is a real differentiator in a Brazilian ecosystem where many funds are capital providers but few are operating partners. Stage focus spans seed and Series A, check sizes in the $250k to $1M range as initial commitments with strong follow-on capacity, and a stated AI focus that has been visible across recent vintages. Healthcare interest centers on health IT, healthcare SaaS, and digital health platforms with B2B distribution. The right founder is a Brazilian technical or technical-commercial team building software that sells to providers, payers, pharma, or consumers in a SaaS or marketplace structure, with a willingness to engage actively with Astella’s playbook including their well-known sales and growth frameworks. Astella tends to do its best work with founders who treat the fund as a coach as well as a check. The wrong founder is a regulated medtech or biotech company, a US-modeled telehealth direct-to-consumer business without Brazilian distribution understanding, or a team that bristles at structured operating support. Intro paths run through Sao Paulo’s deep operator network, Astella’s existing portfolio CEOs many of whom are publicly active, and through frequent co-investors such as Kaszek, Canary, Monashees (Monas), and Valor Capital. Founders First, Endeavor Brazil, and the YC LatAm cohort are also strong on-ramps. Direct application through the Astella site is acknowledged but rarely competitive without a referral. In the pitch, lead with revenue or active pilots, your CAC and payback math even if early, and a candid view of what Brazilian SaaS distribution actually costs, since Astella has more pattern recognition on this than almost any other fund in the country. Show an honest read on the cross-border opportunity, particularly Mexico, since most Brazilian SaaS funds now expect Spanish LatAm optionality. Be specific about LGPD, ANS for payer-side products, ANVISA where applicable, and your data architecture. Caveats are minor: Astella is a strong partner but operates in a competitive Sao Paulo seed market where round timelines have compressed, and founders should expect to move quickly on diligence and term sheets when the firm engages. The methodology orientation is a feature for the right founder and friction for the wrong one.